Roche Molecular Systems
June 2013 — Present
Department: Infectious Diseases
Outlined and conducted a study that compared the efficacy of bacterial swabs between various
⋅ Processed over 144 samples by triplicate plating within a month.
⋅ Produced bacterial glycerol stocks, with titer verification, to help maintain over 12786 organisms in the culture collection.
⋅ Helped update and complete inventory of organisms into new database
⋅ Extracted bacterial DNA using the MagNA Pure LC 2.0 instrument and analyzed purified DNA by PicoGreen®, Nano Drop®, and the Agilent 2800 Tape Station for protocol optimization.